ARCHIVES

Advisors approve set-aside for alternative medicine “best case series.”

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

(8-page issue)

October 4, 2002

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998